These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4487487)

  • 1. Immunotherapeutic approaches to cancer control.
    Warner GA
    AORN J; 1973 May; 17(5):71-4. PubMed ID: 4487487
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy as an Option for Cancer Treatment.
    Rusch T; Bayry J; Werner J; Shevchenko I; Bazhin AV
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):89-96. PubMed ID: 29026920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current problems in the development of specific immunotherapeutic approaches to cancer.
    Dalgleish AG
    J Clin Pathol; 2001 Sep; 54(9):675-6. PubMed ID: 11533071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy: new insights].
    Geissler M; Weth R
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems and prospects of new immunotherapeutic approaches.
    Fridman WH; Mathiot C; Michon J; Teillaud JL; Dorval T; Zucker JM; Pouillart P
    Cancer Detect Prev; 1990; 14(6):657-60. PubMed ID: 2257565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunotherapy: Breakthrough or "deja vu, all over again"?
    Sell S
    Tumour Biol; 2017 Jun; 39(6):1010428317707764. PubMed ID: 28639883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Thirteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-13), October 2-4, 2013, Amsterdam, The Netherlands: the current standing of anti-tumor immunotherapeutic approaches.
    Melief SM; Visconti VV; Doorduijn EM; Santegoets SJ
    Cancer Immunol Immunother; 2014 Oct; 63(10):1105-12. PubMed ID: 24619351
    [No Abstract]   [Full Text] [Related]  

  • 8. [The immunotherapeutic approaches to the management of leukemia and neoplasms].
    Leu TP
    Zhonghua Yi Xue Za Zhi; 1974 May; 5():310-4. PubMed ID: 4211699
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted Nanoparticle Drug Delivery System for the Enhancement of Cancer Immunotherapy.
    Zhang H; Wu Y; Hu Y; Li X; Zhao M; Lv Z
    J Biomed Nanotechnol; 2019 Sep; 15(9):1839-1866. PubMed ID: 31387674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Strategies to Boost Cancer Immunotherapies.
    Barrero MJ
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody and immunotherapy in oncology. Which patients benefit?].
    Schlimok G
    MMW Fortschr Med; 2001 Jun; 143(25):24-8. PubMed ID: 11468992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.
    Makkouk A; Weiner GJ
    Cancer Res; 2015 Jan; 75(1):5-10. PubMed ID: 25524899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is all cancer therapy immunotherapy?
    Belvin M; Mellman I
    Sci Transl Med; 2015 Nov; 7(315):315fs48. PubMed ID: 26606965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the anti-tumor immune response in patients receiving immunotherapy.
    Caushi JX; Smith KN
    Discov Med; 2017 Aug; 24(130):59-68. PubMed ID: 28950076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting conventional cancer treatment for immunotherapy.
    Qiao J; Liu Z; Fu YX
    J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic approaches to the management of neoplasms.
    Klein E; Holtermann OA
    Natl Cancer Inst Monogr; 1972 Dec; 35():379-402. PubMed ID: 4572833
    [No Abstract]   [Full Text] [Related]  

  • 18. IgE immunotherapy against cancer.
    Leoh LS; Daniels-Wells TR; Penichet ML
    Curr Top Microbiol Immunol; 2015; 388():109-49. PubMed ID: 25553797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy: harnessing the immune system to battle cancer.
    Yang Y
    J Clin Invest; 2015 Sep; 125(9):3335-7. PubMed ID: 26325031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell-based immunotherapies in Pediatric Oncology.
    McDowell KA; Hank JA; DeSantes KB; Capitini CM; Otto M; Sondel PM
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):79-93. PubMed ID: 25590232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.